MedPath

Feasibility of Partners in Care Program for Caregivers of Patients With Acute Myeloid Leukemia

Not Applicable
Terminated
Conditions
Acute Myeloid Leukemia
Interventions
Behavioral: Telephone-Based Intervention
Other: Behavioral, Psychological or Informational Intervention
Other: Questionnaire Administration
Registration Number
NCT03806192
Lead Sponsor
University of Washington
Brief Summary

This trial studies the feasibility of delivering the Partners in Care Program to caregivers of patients with acute myeloid leukemia. Psychological counseling interventions, such as the Partners in Care Program, may help to improve caregivers' psychosocial functioning, marital adjustment in the context of the cancer, communication, and support skills to the patient.

Detailed Description

OUTLINE: Participants are randomized to 1 of 2 groups.

GROUP A: Participants attend 5 psychoeducational counseling sessions over 30-60 minutes via telephone.

GROUP B: Participants attend 5 psychoeducational counseling sessions over 30-60 minutes via video teleconference.

After completion of study, participants are followed up at 4 months.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Diagnosis of AML within the recent 2 months
  • Caregivers and patients need to write, read, and speak English as one of their languages of choice; and currently sharing a residence at least 50% of the time together
  • Patient must have no other concurrent cancer diagnosis except for basal or squamous cell
  • Caregiver must be able to sustain up to 60 minutes of interaction with patient educator
  • Ability to understand and the willingness to sign a written informed consent document
Read More
Exclusion Criteria
  • Participants will be excluded if either the patient or the caregiver cannot write, read, and speak English as one of their languages of choice; are not currently sharing a residence at least 50% of the time together
  • The patient cannot have another concurrent cancer diagnosis except for basal or squamous cell
  • Caregiver cannot sustain up to 60 minutes of interaction with the patient educator
  • Caregiver does not have access to a computer with 2-way video capability (i.e. ZOOM) or a cell phone
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group B (psychoeducational counseling sessions in person)Questionnaire AdministrationParticipants attend 5 psychoeducational counseling sessions over 30-60 minutes via video teleconference.
Group A (psychoeducational counseling sessions via telephone)Questionnaire AdministrationParticipants attend 5 psychoeducational counseling sessions over 30-60 minutes via telephone.
Group A (psychoeducational counseling sessions via telephone)Telephone-Based InterventionParticipants attend 5 psychoeducational counseling sessions over 30-60 minutes via telephone.
Group B (psychoeducational counseling sessions in person)Behavioral, Psychological or Informational InterventionParticipants attend 5 psychoeducational counseling sessions over 30-60 minutes via video teleconference.
Primary Outcome Measures
NameTimeMethod
Rate of recruitmentUp to 1 year
Rate of enrollmentUp to 1 year
Rate of completion of 5-session interventionUp to 1 year
Secondary Outcome Measures
NameTimeMethod
Change in standardized measures of caregiver and patients' scores in each group on anxiety (State-Trait Anxiety Inventory [STAI])Baseline up to 4 months

Will assess the within-group changes using the one-sample t-test or the signed-rank test, as appropriate.

Change in standardized measures of caregiver and patients' scores in each group on depressed mood (Center for Epidemiologic Studies Depression Scale [CES-D])Baseline up to 4 months

Will assess the within-group changes using the one-sample t-test or the signed-rank test, as appropriate.

Change in standardized measures of caregiver and patients' scores in each group on Spouse Skills ChecklistBaseline up to 4 months

Will assess the within-group changes using the one-sample t-test or the signed-rank test, as appropriate.

Change in standardized measures of caregiver and patients' scores in each group on Cancer Self-efficacy (CASE)Baseline up to 4 months

Will assess the within-group changes using the one-sample t-test or the signed-rank test, as appropriate.

Trial Locations

Locations (1)

Fred Hutch/University of Washington Cancer Consortium

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath